RNA, 7SL, cytoplasmic 452, pseudogene (RN7SL452P)

RN7SL452P refers to a pseudogene derived from the 7SL RNA gene, which is a non-coding RNA component of the signal recognition particle (SRP)[1][5][6][8]. However, RN7SL452P itself is not a functional gene; it is classified as a pseudogene, meaning it does not encode a functional RNA or protein, and is not a therapeutic target, receptor, enzyme, transporter, or other druggable biological entity[1][4][7]. The canonical 7SL RNA participates in co-translational protein targeting to the endoplasmic reticulum, but RN7SL452P and most other dispersed 7SL pseudogenes in the human genome are non-functional truncated copies created by reverse transcription and integration processes[5][6][8]. No biological functions, disease roles, or clinical drug interactions are known for this pseudogene. It is neither a biomarker nor associated with therapeutic safety concerns. Panels and gene databases do not include RN7SL452P as a phenotype-associated or actionable entity[4][1]. The presence of an unusually large number of 7SL RNA-related pseudogenes in the human genome, many of which are variably truncated, reflects genomic repetitive element activity (e.g., Alu repeats originated from 7SL RNA)[3][5][6]. RN7SL452P is not considered a correct or relevant drug target; if listed as such, this is an error[4][1][5][8].

Other names

RN7SL452PRNA, 7SL, cytoplasmic 452, pseudogene